Diagnosis-Related Groups

诊断相关组
  • 文章类型: Journal Article
    背景:本研究通过分析诊断相关群体(DRGs)支付系统在中国和全球的研究现状,探讨DRGs在不同发展阶段的演变趋势。
    方法:从中国国家知识基础设施(CNKI)数据库和WebofScience(WoS)核心数据库中提取DRG领域的相关文献摘要,并用作文本数据。基于概率分布的潜在狄利克雷分配(LDA)主题模型用于挖掘文本主题。主题问题由主题强度决定,计算相邻阶段主题的余弦相似度,分析主题演变趋势。
    结果:共纳入6,758篇英文文章和3,321篇中文文章。国外对DRGs的研究主要集中在分组优化,实施效果,和影响因素,而中国的研究课题侧重于分组和支付机制的建立,医疗费用变化评估,医疗质量控制,和绩效管理改革探索。
    结论:目前,我国DRGs领域发展迅速,研究不断深入。然而,与国外的深入研究相比,我国的研究实施深度仍然不足。
    BACKGROUND: This study reviews the research status of Diagnosis-related groups (DRGs) payment system in China and globally by analyzing topical issues in this field and exploring the evolutionary trends of DRGs in different developmental stages.
    METHODS: Abstracts of relevant literature in the field of DRGs were extracted from the China National Knowledge Infrastructure (CNKI) database and the Web of Science (WoS) core database and used as text data. A probabilistic distribution-based Latent Dirichlet Allocation (LDA) topic model was applied to mine the text topics. Topical issues were determined by topic intensity, and the cosine similarity of the topics in adjacent stages was calculated to analyze the topic evolution trend.
    RESULTS: A total of 6,758 English articles and 3,321 Chinese articles were included. Foreign research on DRGs focuses on grouping optimization, implementation effects, and influencing factors, whereas research topics in China focus on grouping and payment mechanism establishment, medical cost change evaluation, medical quality control, and performance management reform exploration.
    CONCLUSIONS: Currently, the field of DRGs in China is developing rapidly and attracting deepening research. However, the implementation depth of research in China remains insufficient compared with the in-depth research conducted abroad.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:2019年冠状病毒(COVID-19)大流行导致手术活动严重中断,尤其是在第一年(2020年)。这项研究的目的是评估2020年和2021年意大利北部手术重组对手术结果的影响。
    方法:在参与手术部位感染(SSIs)监测系统的30家医院中进行了一项回顾性队列研究。考虑在2018年至2021年之间进行的腹部外科手术。根据2018-2019年的数据估算2020年和2021年的预测SSI率,并与观察到的比率进行比较。使用逻辑回归调查了SSI的独立预测因素,包括程序年份。
    结果:包括7605程序。比较三个时间段,发现病例组合存在显着差异。根据2018-2019年的SSI率(p0.0465),观察到的2020年所有患者的SSI率均显着低于预期。2020年接受癌症手术以外手术的患者发生SSI的几率显著降低(比值比,或0.52,95%置信区间,CI0.3-0.89,p0.018),与2018-2019年相比,2021年接受手术的患者发生SSI的几率明显更高(OR1.49,95%CI1.07-2.09,p0.019)。
    结论:加强感染预防和控制(IPC)措施可以解释在大流行的第一年降低的SSI风险。在大流行范围之外,应继续加强IPC做法。
    BACKGROUND: The coronavirus 2019 (COVID-19) pandemic led to major disruptions in surgical activity, particularly in the first year (2020). The objective of this study was to assess the impact of surgical reorganization on surgical outcomes in Northern Italy in 2020 and 2021.
    METHODS: A retrospective cohort study was conducted among 30 hospitals participating in the surveillance system for surgical site infections (SSIs). Abdominal surgery procedures performed between 2018 and 2021 were considered. Predicted SSI rates for 2020 and 2021 were estimated based on 2018-2019 data and compared with observed rates. Independent predictors for SSI were investigated using logistic regression, including procedure year.
    RESULTS: 7605 procedures were included. Significant differences in case-mix were found comparing the three time periods. Observed SSI rates among all patients in 2020 were significantly lower than expected based on 2018-2019 SSI rates (p 0.0465). Patients undergoing procedures other than cancer surgery in 2020 had significantly lower odds for SSI (odds ratio, OR 0.52, 95 % confidence interval, CI 0.3-0.89, p 0.018) and patients undergoing surgery in 2021 had significantly higher odds for SSI (OR 1.49, 95 % CI 1.07-2.09, p 0.019) compared to 2018-2019.
    CONCLUSIONS: Enhanced infection prevention and control (IPC) measures could explain the reduced SSI risk during the first pandemic year. IPC practices should continue to be reinforced beyond the pandemic context.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:急性心肌梗死(AMI)的院内死亡率在国际比较中被广泛用作卫生系统性能的指标。由于AMI后早期死亡的风险很高,国际比较可能因住院患者早期死亡病例记录的差异而存在偏差.这项研究以德国和美国为例,研究了早期死亡记录的差异是否会影响AMI住院死亡率的国际比较。并探讨了解决这一问题的方法。
    方法:德国诊断相关组统计(DRG统计),分析了2014年至2019年美国全国住院患者样本(NIS)和美国全国急诊科样本(NEDS).在德国和美国的住院数据中确定了接受AMI治疗的病例。从NEDS数据中提取了在急诊科(ED)没有住院的AMI死亡。30天住院死亡率数字是根据OECD指标定义(未关联数据)计算的,并通过包括ED死亡来修改。或排除所有同一天的情况。
    结果:德国年龄和性别标准化的30天住院死亡率明显高于美国(2019年,7.3%vs.4.6%)。德国与德国的比率美国死亡率为1.6。在美国数据中纳入ED死亡人数后,这一比率下降到1.4。在德国和美国的数据中排除当天的病例导致了类似的比率。
    结论:虽然早期死亡导致的短期治疗通常记录在德国住院数据中,在美国的住院数据中,这些病例部分缺失。从死亡率指标的计算中排除短期治疗的病例可能是解释早期死亡记录差异的可行方法,这在其他国家也可能存在。
    BACKGROUND: In-hospital mortality from acute myocardial infarction (AMI) is widely used in international comparisons as an indicator of health system performance. Because of the high risk of early death after AMI, international comparisons may be biased by differences in the recording of early death cases in hospital inpatient data. This study examined whether differences in the recording of early deaths affect international comparisons of AMI in-hospital mortality by using the example of Germany and the United States, and explored approaches to address this issue.
    METHODS: The German Diagnosis-Related Groups Statistics (DRG Statistics), the U.S. National Inpatient Sample (NIS) and the U.S. Nationwide Emergency Department Sample (NEDS) were analysed from 2014 to 2019. Cases with treatment for AMI were identified in German and U.S. inpatient data. AMI deaths occurring in the emergency department (ED) without inpatient admission were extracted from NEDS data. 30-day in-hospital mortality figures were calculated according to the OECD indicator definition (unlinked data) and modified by including ED deaths, or excluding all same-day cases.
    RESULTS: German age-and-sex standardized 30-day in-hospital mortality was substantially higher compared to the U.S. (in 2019, 7.3% vs. 4.6%). The ratio of German vs. U.S. mortality was 1.6. After inclusion of ED deaths in U.S. data this ratio declined to 1.4. Exclusion of same-day cases in German and U.S. data led to a similar ratio.
    CONCLUSIONS: While short-duration treatments due to early death are generally recorded in German inpatient data, in U.S. inpatient data those cases are partially missing. Excluding cases with short-duration treatment from the calculation of mortality indicators could be a feasible approach to account for differences in the recording of early deaths, that might be existent in other countries as well.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:先前的研究发现,当退伍军人在退伍军人健康管理局(VHA)内部接受护理时,合并症的记录有所不同。医疗中心资金的变化,增加对业绩报告的关注,以及临床文档改进计划的扩展,然而,可能导致VHA中的编码发生变化。
    方法:使用重复的横截面数据,我们比较了Elixhauser-vanWalraven评分和Medicare严重程度诊断相关组(DRG)在不同设置和付款人之间的退伍军人入院严重程度,利用美国七个州2012-2017年的VHA和所有付款人出院数据的联系。为了最小化选择偏差,我们分析了同年VHA和非VHA医院收治的退伍军人的记录.使用广义线性模型,我们根据患者和医院的特点进行了调整.
    结果:调整后,VHA入院的预测平均合并症得分最低(4.44(95%CI4.34-4.55)),使用最严重DRG的概率最低(22.1%(95%CI21.4%-22.8%))。相比之下,医疗保险覆盖的入院患者预测平均合并症得分最高(5.71(95%CI5.56-5.85)),使用最高DRG的概率最高(35.3%(95%CI34.2%-36.4%))。
    结论:可能需要更有效的策略来改进VHA文档,当前的风险调整比较应考虑编码强度的差异。
    BACKGROUND: Previous studies found that documentation of comorbidities differed when Veterans received care within versus outside Veterans Health Administration (VHA). Changes to medical center funding, increased attention to performance reporting, and expansion of Clinical Documentation Improvement programs, however, may have caused coding in VHA to change.
    METHODS: Using repeated cross-sectional data, we compared Elixhauser-van Walraven scores and Medicare Severity Diagnosis Related Group (DRG) severity levels for Veterans\' admissions across settings and payers over time, utilizing a linkage of VHA and all-payer discharge data for 2012-2017 in seven US states. To minimize selection bias, we analyzed records for Veterans admitted to both VHA and non-VHA hospitals in the same year. Using generalized linear models, we adjusted for patient and hospital characteristics.
    RESULTS: Following adjustment, VHA admissions consistently had the lowest predicted mean comorbidity scores (4.44 (95% CI 4.34-4.55)) and lowest probability of using the most severe DRG (22.1% (95% CI 21.4%-22.8%)). In contrast, Medicare-covered admissions had the highest predicted mean comorbidity score (5.71 (95% CI 5.56-5.85)) and highest probability of using the top DRG (35.3% (95% CI 34.2%-36.4%)).
    CONCLUSIONS: More effective strategies may be needed to improve VHA documentation, and current risk-adjusted comparisons should account for differences in coding intensity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本研究测量了实施基于诊断相关组(DRG)的计分支付政策后的住院表现差异。点值是动态的;它的变化取决于当年的年度DRGs成本结算和点,这是在第二年年初计算的。
    方法:一项纵向研究,使用稳健的多中断时间序列模型来评估策略实施后的服务性能。
    方法:温州市22家公立综合医院(8家三级机构和14家二级机构),中国。
    方法:干预措施于2020年1月实施。
    方法:指标为病例组合指数(CMI),每次住院费用(CPH),平均住院时间(ALOS),成本效率指数(CEI)和时间效率指数(TEI)。这项研究采用了这些指标的手段。
    结果:2020年1月底到达浙江省的COVID-19的影响是在采取严格的控制措施后暂时得到快速遏制的。干预之后,除了ALOS的意思,其他结局的变化点(p<0.05)在高等教育机构和中学机构不一致.与以前相比,三级(p<0.01)和二级(p<0.0001)机构的CMI平均值呈上升趋势。尽管CPH平均值的斜率没有变化(p>0.05),高等教育机构CEI平均值的上升趋势有所缓解(p<0.05),而二级机构则进一步增加(p<0.05)。二级机构的ALOS和TEI平均值的斜率发生变化(p<0.05),但在大专院校中没有(p>0.05)。
    结论:这项研究显示了温州DRG政策的积极作用,即使在COVID-19期间。该政策可以激励公立综合医院提高综合能力,减轻同类疾病治疗费用效率的差异。政策制定者对改革是否成功激励医院增强内部动力和改善绩效感兴趣,这得到了这项研究的支持。
    OBJECTIVE: This study measures the differences in inpatient performance after a points-counting payment policy based on diagnosis-related group (DRG) was implemented. The point value is dynamic; its change depends on the annual DRGs\' cost settlements and points of the current year, which are calculated at the beginning of the following year.
    METHODS: A longitudinal study using a robust multiple interrupted time series model to evaluate service performance following policy implementation.
    METHODS: Twenty-two public general hospitals (8 tertiary institutions and 14 secondary institutions) in Wenzhou, China.
    METHODS: The intervention was implemented in January 2020.
    METHODS: The indicators were case mix index (CMI), cost per hospitalisation (CPH), average length of stay (ALOS), cost efficiency index (CEI) and time efficiency index (TEI). The study employed the means of these indicators.
    RESULTS: The impact of COVID-19, which reached Zhejiang Province at the end of January 2020, was temporary given rapid containment following strict control measures. After the intervention, except for the ALOS mean, the change-points for the other outcomes (p<0.05) in tertiary and secondary institutions were inconsistent. The CMI mean turned to uptrend in tertiary (p<0.01) and secondary (p<0.0001) institutions compared with before. Although the slope of the CPH mean did not change (p>0.05), the uptrend of the CEI mean in tertiary institutions alleviated (p<0.05) and further increased (p<0.05) in secondary institutions. The slopes of the ALOS and TEI mean in secondary institutions changed (p<0.05), but not in tertiary institutions (p>0.05).
    CONCLUSIONS: This study showed a positive effect of the DRG policy in Wenzhou, even during COVID-19. The policy can motivate public general hospitals to improve their comprehensive capacity and mitigate discrepancies in treatment expenses efficiency for similar diseases. Policymakers are interested in whether the reform successfully motivates hospitals to strengthen their internal impetus and improve their performance, and this is supported by this study.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    诊断相关组(DRG)或诊断干预分组(DIP)支付系统,现在引入中国,打算简化医疗保健账单做法。然而,它对临床药师的影响,医疗保健系统中的关键利益相关者,没有充分探索。这项研究试图评估人们的看法,挑战,以及在引入DRG或DIP支付系统后,中国临床药师的作用。
    对临床药师进行了定性访谈。进行了十次半结构化访谈,无论是在线还是面对面。采用主题分析来确定DRG或DIP系统下与其专业前景相关的关键见解和关注点。
    临床药师对DRG或DIP系统的认识程度不同。他们的角色经历了转变,在传统责任和DRG或DIP系统规定的新义务之间建立平衡。专业发展,特别是关于卫生经济学和基于DRG或基于DIP的患者护理,被强调为关键需求。有人呼吁在医疗保健和国家层面提供政策支持,并进行了修订,整体绩效评估系统。对更多资源的需求,无论是在培训平台还是人员,是一个反复出现的主题。
    DRG或DIP系统在中国的引入给临床药师带来了机遇和挑战。解决意识差距,提供强有力的政策支持,确保充分的资源分配,认识到药剂师不断发展的作用对于将DRG或DIP系统和谐地整合到中国医疗保健范式中至关重要。
    The Diagnosis-Related Group (DRG) or Diagnosis-Intervention Packet (DIP) payment system, now introduced in China, intends to streamline healthcare billing practices. However, its implications for clinical pharmacists, pivotal stakeholders in the healthcare system, remain inadequately explored. This study sought to assess the perceptions, challenges, and roles of clinical pharmacists in China following the introduction of the DRG or DIP payment system.
    Qualitative interviews were conducted among a sample of clinical pharmacists. Ten semi-structured interviews were conducted, either online or face to face. Thematic analysis was employed to identify key insights and concerns related to their professional landscape under the DRG or DIP system.
    Clinical pharmacists exhibited variable awareness levels about the DRG or DIP system. Their roles have undergone shifts, creating a balance between traditional responsibilities and new obligations dictated by the DRG or DIP system. Professional development, particularly concerning health economics and DRG-based or DIP-based patient care, was highlighted as a key need. There were calls for policy support at both healthcare and national levels and a revised, holistic performance assessment system. The demand for more resources, be it in training platforms or personnel, was a recurrent theme.
    The DRG or DIP system\'s introduction in China poses both opportunities and challenges for clinical pharmacists. Addressing awareness gaps, offering robust policy support, ensuring adequate resource allocation, and recognizing the evolving role of pharmacists are crucial for harmoniously integrating the DRG or DIP system into the Chinese healthcare paradigm.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:根据诊断相关组(DRG)的要求,分析我院消化内科诊断和程序编码存在的问题,提出改进方案,为有效实施DRGs奠定基础。
    方法:以2021年1月1日至2021年12月31日该院消化内科收治的1600名患者的病例-病史标题页为数据来源,以及主要和其他诊断代码,对病例历史标题页中涉及的操作或程序代码进行分类和统计分析。
    结果:在2021年在我院接受胃肠内镜检查的531例中,发现编码错误的有66例,未成功的有35例DRG入组,包括14例主要诊断编码不正确的病例(8例DRG入组失败的病例),37例主要操作编码不正确(23例DRG注册不成功),8例主要诊断和主要手术编码错误(4例DRG入组失败)。66例存在编码问题的住院病例分析显示,共有167例存在缺陷,包括36项重大诊断缺陷,其他诊断中的84个缺陷,和47个手术或手术编码缺陷。
    结论:疾病诊断和外科手术编码的准确性是DRGs顺利实施的基础。该院医务人员对DRGs编码认知较差,未能认识到病例历史质量的标题页对DRGs系统的重要作用,应提高对DRGs和疾病分类编码知识库的重视程度。此外,编码错误的高发生率,尤其是疾病诊断的遗漏,需要增加对医生和护士的临床知识和DRGs医疗记录要求的培训,从而提高了医疗病例的质量,保证了DRGs信息的准确性。
    OBJECTIVE: According to the diagnosis-related group (DRG) requirement, issues of diagnosis and procedure coding in the gastroenterology department of our hospital were analyzed and improvement plans were proposed to lay the foundation for effective implementation of DRGs.
    METHODS: The title page of case-history of 1600 patients admitted to the Department of Gastroenterology of this hospital from January 1, 2021 to December 31, 2021 was sampled as a data source, and the primary and other diagnostic codes, operation or procedure codes involved in the title page of case-history were categorized and statistically analyzed.
    RESULTS: Of the 531 cases treated with gastrointestinal endoscopy in our hospital in 2021, coding errors were identified in 66 cases and unsuccessful DRG enrollment in 35 cases, including 14 cases with incorrect coding of the primary diagnosis (8 cases with unsuccessful DRG enrollment), 37 cases with incorrect coding of the primary operation (23 cases with unsuccessful DRG enrollment), and 8 cases with incorrect coding of both the primary diagnosis and the primary operation (4 cases with unsuccessful DRG enrollment). Analysis of 66 inpatient cases with coding problems showed a total of 167 deficiencies, including 36 deficiencies in major diagnoses, 84 deficiencies in other diagnoses, and 47 deficiencies in surgery or operation coding.
    CONCLUSIONS: The accuracy of coding of disease diagnosis and surgical operation is the basis for the smooth implementation of DRGs. The medical staff of this hospital has poor cognition of DRGs coding and fails to recognize the important role of the title page of case-history quality to DRGs system, and their attention to DRGs and knowledge base of disease classification coding should be improved. In addition, the high incidence of coding errors, especially the omission of disease diagnosis, requires increased training of physicians and nurses on clinical knowledge and requirements for DRGs medical records, thereby improving the quality of medical cases and ensuring the accuracy of DRGs information.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在过去的20年中,腰椎融合的使用已大大增加。对于腰椎管狭窄和退行性腰椎滑脱的患者,2016年在《新英格兰医学杂志》上发表的2项具有里程碑意义的前瞻性随机临床试验(RCTs)没有发现明确的证据表明该人群中融合减压优于单纯减压。
    评估2016年至2019年在全国范围内使用减压融合术与单纯减压术治疗腰椎管狭窄症和退行性腰椎滑脱症。
    这项回顾性队列研究包括从2016年1月1日至2019年12月31日接受单独一级减压或减压融合治疗腰椎管狭窄和退行性腰椎滑脱的121745例住院成年患者(年龄≥18岁)。所有数据均来自全国住院患者样本(NIS)。进行了分析,reviewed,或更新于2023年6月9日。
    本研究的主要结果是使用融合减压与单独减压。对于次要结果,多变量logistic回归分析用于评估与决定进行融合减压与单独减压的相关因素。
    在121745名符合条件的住院患者中(平均年龄,65.2年[95%CI,65.0-65.4年];96645/117640[82.2%]非西班牙裔白人)伴有腰椎管狭窄和退行性腰椎滑脱,21230例(17.4%)仅接受减压,和100515(82.6%)接受减压融合。仅接受减压的患者比例从2016年(23405中的7625例[32.6%])下降到2019年(37215中的3560例[9.6%]),而同期接受减压融合治疗的患者比例有所增加(从2016年的23405例患者中的15780例[67.4%]增加到2019年的37215例患者中的33655例[90.4%]).在单变量分析中,仅接受减压的患者与接受融合减压的患者在年龄方面存在显着差异(平均,68.6年[95%CI,68.2-68.9年]vs64.5年[95%CI,64.3-64.7年];P<.001),保险状况(例如,医疗保险:21205中的13725[64.7%]对100420中的53320[53.1%];P<.001),所有患者精细诊断相关组死亡风险(例如,轻微风险:16900[79.6%]对83730[83.3%];P<.001),和国家的医院地区(例如,南部:7030[33.1%]对38905[38.7%];中西部:4470[21.1%]对23360[23.2%];两个比较P<.001)。在多变量逻辑回归分析中,年龄较大(调整后的赔率比[AOR],每年0.96;95%CI,每年0.95-0.96),2016年后的一年(AOR,每年1.76;95%CI,每年1.69-1.85),自付保险状态(AOR,0.59;95%CI,0.36-0.95),中型医院规模(AOR,0.77;95%CI,0.67-0.89),大型医院规模(AOR,0.76;95%CI,0.67-0.86),和按患者居住邮政编码划分的最高中位数收入四分位数(AOR,0.79;95%CI,0.70-0.89)与接受减压融合的几率较低相关。相反,中西部的医院地区(AOR,1.34;95%CI,1.14-1.57)或南方(AOR,1.32;95%CI,1.14-1.54)与接受减压融合的几率更高相关。融合减压术与单纯减压术与住院时间延长相关(平均,2.96天[95%CI,2.92-3.01天]vs2.55天[95%CI,2.49-2.62天];P<.001),较高的总入学费用(平均,$30288[95%CI,$29386-$31189]vs$16190[95%CI,$15189-$17191];P<.001),和更高的总入学费用(平均,$121892[95%CI,$119566-$124219]vs$82197[95%CI,$79745-$84648];P<.001)。
    在这项队列研究中,尽管有2个前瞻性RCT证明了单独减压与融合减压相比的非劣效性,从2016年到2019年,融合减压的使用相对于单独减压增加。各种患者和医院水平的因素与手术方式的选择有关。这些结果表明,两个主要RCT的发现尚未改变手术实践模式,值得重新关注。
    Use of lumbar fusion has increased substantially over the last 2 decades. For patients with lumbar stenosis and degenerative spondylolisthesis, 2 landmark prospective randomized clinical trials (RCTs) published in the New England Journal of Medicine in 2016 did not find clear evidence in favor of decompression with fusion over decompression alone in this population.
    To assess the national use of decompression with fusion vs decompression alone for the surgical treatment of lumbar stenosis and degenerative spondylolisthesis from 2016 to 2019.
    This retrospective cohort study included 121 745 hospitalized adult patients (aged ≥18 years) undergoing 1-level decompression alone or decompression with fusion for the management of lumbar stenosis and degenerative spondylolisthesis from January 1, 2016, to December 31, 2019. All data were obtained from the National Inpatient Sample (NIS). Analyses were conducted, reviewed, or updated on June 9, 2023.
    The primary outcome of this study was the use of decompression with fusion vs decompression alone. For the secondary outcome, multivariable logistic regression analysis was used to evaluate factors associated with the decision to perform decompression with fusion vs decompression alone.
    Among 121 745 eligible hospitalized patients (mean age, 65.2 years [95% CI, 65.0-65.4 years]; 96 645 of 117 640 [82.2%] non-Hispanic White) with lumbar stenosis and degenerative spondylolisthesis, 21 230 (17.4%) underwent decompression alone, and 100 515 (82.6%) underwent decompression with fusion. The proportion of patients undergoing decompression alone decreased from 2016 (7625 of 23 405 [32.6%]) to 2019 (3560 of 37 215 [9.6%]), whereas the proportion of patients undergoing decompression with fusion increased over the same period (from 15 780 of 23 405 [67.4%] in 2016 to 33 655 of 37 215 [90.4%] in 2019). In univariable analysis, patients undergoing decompression alone differed significantly from those undergoing decompression with fusion with regard to age (mean, 68.6 years [95% CI, 68.2-68.9 years] vs 64.5 years [95% CI, 64.3-64.7 years]; P < .001), insurance status (eg, Medicare: 13 725 of 21 205 [64.7%] vs 53 320 of 100 420 [53.1%]; P < .001), All Patient Refined Diagnosis Related Group risk of death (eg, minor risk: 16 900 [79.6%] vs 83 730 [83.3%]; P < .001), and hospital region of the country (eg, South: 7030 [33.1%] vs 38 905 [38.7%]; Midwest: 4470 [21.1%] vs 23 360 [23.2%]; P < .001 for both comparisons). In multivariable logistic regression analysis, older age (adjusted odds ratio [AOR], 0.96 per year; 95% CI, 0.95-0.96 per year), year after 2016 (AOR, 1.76 per year; 95% CI, 1.69-1.85 per year), self-pay insurance status (AOR, 0.59; 95% CI, 0.36-0.95), medium hospital size (AOR, 0.77; 95% CI, 0.67-0.89), large hospital size (AOR, 0.76; 95% CI, 0.67-0.86), and highest median income quartile by patient residence zip code (AOR, 0.79; 95% CI, 0.70-0.89) were associated with lower odds of undergoing decompression with fusion. Conversely, hospital region in the Midwest (AOR, 1.34; 95% CI, 1.14-1.57) or South (AOR, 1.32; 95% CI, 1.14-1.54) was associated with higher odds of undergoing decompression with fusion. Decompression with fusion vs decompression alone was associated with longer length of stay (mean, 2.96 days [95% CI, 2.92-3.01 days] vs 2.55 days [95% CI, 2.49-2.62 days]; P < .001), higher total admission costs (mean, $30 288 [95% CI, $29 386-$31 189] vs $16 190 [95% CI, $15 189-$17 191]; P < .001), and higher total admission charges (mean, $121 892 [95% CI, $119 566-$124 219] vs $82 197 [95% CI, $79 745-$84 648]; P < .001).
    In this cohort study, despite 2 prospective RCTs that demonstrated the noninferiority of decompression alone compared with decompression with fusion, use of decompression with fusion relative to decompression alone increased from 2016 to 2019. A variety of patient- and hospital-level factors were associated with surgical procedure choice. These results suggest the findings of 2 major RCTs have not yet produced changes in surgical practice patterns and deserve renewed focus.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    近年来,中国已实施诊断相关团体(DRG)支付系统,作为其医疗保险报销政策的一部分。许多研究都集中在DRG支付系统在控制医疗费用不合理增长方面的有效性。然而,关于DRG支付系统下医生表现出的非预期行为类型,尚无系统报告.
    该研究首先利用中断时间序列分析来分析来自八家医院的医疗记录和保险数据。它调查了DRG支付系统实施前后MDC和ADRG组的数据变化。随后,采用半结构化访谈方法对医生的非预期行为进行定性研究,旨在更准确地了解实施DRG支付系统后医师行为的具体变化。
    这项研究发现,医生在DRG支付系统的框架内从事非预期行为。
    在中国早期实施DRG支付系统时,有缺陷的DRG支付方式和配套制度与实际诊疗工作之间的矛盾表现为非预期的医生行为。这些意外行为中的大多数可以被认为是医生的合理反馈,以应对现有的系统缺陷。这有助于发现我国DRG支付体系存在的不足并提出改进方向。
    In recent years, China has implemented the Diagnosis Related Groups (DRG) payment system as part of its healthcare insurance reimbursement policy. Numerous studies have focused on the effectiveness of DRG payment system in controlling unreasonable growth in medical expenses. However, there has been no systematic report on the types of unintended behaviors exhibited by doctors under the DRG payment system.
    The study first utilized interrupted time series analysis to analyze medical records and insurance data from eight hospitals. It investigated the data changes in MDC and ADRG groups before and after the implementation of the DRG payment system. Subsequently, a semi-structured interview method was employed to conduct qualitative research on the unintended behaviors of physicians, aiming to gain a more accurate understanding of specific changes in physician behavior after the implementation of the DRG payment system.
    This study discovered that doctors engage in unintended behaviors within the framework of the DRG payment system.
    In the early implementation of the DRG payment system in China, the contradictions between the flawed DRG payment methods and supporting systems and the actual diagnostic and treatment work manifested in the form of unintended doctor behaviors. Most of these unintended behaviors can be considered reasonable feedback from doctors to cope with the existing system flaws. They are conducive to identifying the deficiencies in China\'s DRG payment system and suggesting directions for improvement.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:医院活动通常使用与诊断相关的小组进行测量,或案例混合组,但这些信息并不代表患者健康结果的重要方面。这项研究报告了温哥华择期(计划)手术患者健康状况的基于病例组合的变化,加拿大。
    方法:我们在温哥华的六家急性护理医院中使用了计划住院或门诊手术的连续患者的前瞻性招募队列。所有参与者在术前和术后6个月完成EQ-5D(5L),收集时间为2015年10月至2020年9月,并与出院数据相关联。主要结果是不同住院和门诊病例组患者自我报告的健康状况是否得到改善。
    结果:该研究包括1665名参与者,他们在术前和术后完成了EQ-5D(5L),在八个住院和门诊手术病例组合类别中,参与率为44.8%。通过效用值和视觉模拟量表评分衡量,所有病例组合类别均与健康状况的统计学显着增加(p<.01或更低)相关。足踝手术患者的术前健康状况最低(平均效用值:0.6103),而减肥手术患者报告的健康状况改善最大(效用值平均增加:0.1515)。
    结论:本研究提供的证据表明,在加拿大一个省的医院系统中,以一致的方式比较不同病例组合类别的手术患者报告的结果是可行的。报告手术病例组合类别的健康状况变化可确定患者更有可能在健康方面获得显着收益的特征。
    Hospital activity is often measured using diagnosis-related groups, or case mix groups, but this information does not represent important aspects of patients\' health outcomes. This study reports on case mix-based changes in health status of elective (planned) surgery patients in Vancouver, Canada.
    We used a prospectively recruited cohort of consecutive patients scheduled for planned inpatient or outpatient surgery in six acute care hospitals in Vancouver. All participants completed the EQ-5D(5L) preoperatively and 6 months postoperatively, collected from October 2015 to September 2020 and linked with hospital discharge data. The main outcome was whether patients\' self-reported health status improved among different inpatient and outpatient case mix groups.
    The study included 1665 participants with completed EQ-5D(5L) preoperatively and postoperatively, representing a 44.8% participation rate across eight inpatient and outpatient surgical case mix categories. All case mix categories were associated with a statistically significant gain in health status (p < .01 or lower) as measured by the utility value and visual analogue scale score. Foot and ankle surgery patients had the lowest preoperative health status (mean utility value: 0.6103), while bariatric surgery patients reported the largest improvements in health status (mean gain in utility value: 0.1515).
    This study provides evidence that it was feasible to compare patient-reported outcomes across case mix categories of surgical patients in a consistent manner across a system of hospitals in one province in Canada. Reporting changes in health status of operative case mix categories identifies characteristics of patients more likely to experience significant gains in health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号